Department of ophtalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Henan Province People's Hospital, Henan Provincial Ophthalmology Hospital, Zhengzhou, 450003, China.
Sci Rep. 2019 Sep 25;9(1):13869. doi: 10.1038/s41598-019-50383-x.
We compared the therapeutic effects between botulinum toxin and surgery for acute acquired comitant esotropia (AACE) and analyze its clinical characteristics. The data of the 29 cases, who received treatment for AACE in the Ophthalmic Center of the First Affiliated Hospital of Zhengzhou University and Henan Provincial Ophthalmology Hospital between January 2016 and January 2017, were collected. The 29 cases with AACE were followed for 6 months or more, and received either botulinum toxin injection (group A with 13 cases) or squint correction (group B with 16 cases). The distant and near deviation angles were compared between the two groups before and after treatment. The success rate (total horizontal deviation of 10 prism diopters or less) and stereopsis were compared between the two groups at post-treatment 6 months. At the same time, the relations between distant and near deviation angles were analyzed among different myopia levels and different AACE types. Results indicated that he success rate was not significantly different at post-treatment 6 months (84.6% vs 81.3%, P = 1.00). The distant and near deviation angles were all significantly different one day and one month after treatment (all P < 0.05); but at post-treatment 6 months, they were not significantly different (all P > 0.05) between the two groups. There were no significant differences in the distant and near stereoacuity between the two groups at post-treatment 6 months (all P > 0.05). Among the 25 cases with myopia, the pre-treatment distant deviation angle was significantly higher than pre-treatment near deviation angle in the cases with myopia level >-2.5 D (P < 0.05), and the pre-treatment distant and near deviation angles were all significantly higher in the cases with type-IIAACE than in the cases with type-IIIAACE (all P < 0.05). This study suggests that Botulinum toxin is as effective as surgery in the treatment of AACE at post-treatment 6 months. For the cases with myopia level >-2.5 D, the pre-treatment distant deviation angle is significantly higher than pre-treatment near deviation angle; and both pre-treatment distant and near deviation angles are greater in the cases with type-IIAACE than in the cases with type-IIIAACE.
我们比较了肉毒毒素与手术治疗急性获得性共同性内斜视(AACE)的疗效,并分析了其临床特征。收集了 2016 年 1 月至 2017 年 1 月期间在郑州大学第一附属医院和河南省眼科医院眼科中心接受 AACE 治疗的 29 例患者的数据。29 例 AACE 患者随访 6 个月以上,分别接受肉毒毒素注射(A 组 13 例)或斜视矫正(B 组 16 例)。比较两组治疗前后的远、近斜视角度。比较两组治疗后 6 个月的成功率(总水平斜视度 10 棱镜度或更小)和立体视锐度。同时,分析不同近视水平和不同 AACE 类型的远、近斜视角度之间的关系。结果显示,治疗后 6 个月时,两组的成功率无显著性差异(84.6%比 81.3%,P=1.00)。治疗后 1 天和 1 个月,两组的远、近斜视角度均有显著性差异(均 P<0.05);但治疗后 6 个月时,两组间无显著性差异(均 P>0.05)。治疗后 6 个月时,两组的远、近立体视锐度无显著性差异(均 P>0.05)。在 25 例近视患者中,近视水平>-2.5D 的患者治疗前远斜视角度明显高于近斜视角度(P<0.05),2AACE 型患者的治疗前远、近斜视角度均明显高于 3AACE 型患者(均 P<0.05)。本研究表明,肉毒毒素治疗 AACE 的疗效与手术相当,治疗后 6 个月。对于近视水平>-2.5D 的患者,治疗前远斜视角度明显高于近斜视角度;2AACE 型患者的治疗前远、近斜视角度均大于 3AACE 型患者。